Aller au contenu principal
Profil bibliographique

CATHERINE M. DUNN

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

63Publications signalées
313Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsGastric Cancer Management and OutcomesGenetic factors in colorectal cancerCancer Genomics and Diagnostics

Les publications récentes

Accès ouvert 2026 article OpenAlex

Diagnostic and treatment intervals for colorectal cancer and associations with overall survival and disease stage: an Australian data linkage study.

Allison Drosdowsky, Karen Elaine Lamb, Luc te Marvelde, Peter Gibbs et autres

Introduction Timeliness in colorectal cancer diagnosis and treatment is crucial, however recommendations are often not evidence based. This study aimed to assess associations between the length of diagnostic and treatment interval and overall survival and stage of disease in colorectal cancer using …

au (code pays fourni par la source)

0 citations Clinical Colorectal Cancer
Accès ouvert 2026 preprint OpenAlex

A scoping review of dashboards to measure and improve quality of care in oncology (Preprint)

Grace Y Kim, Eugene Wang, Saskia Freytag, Sarah A. Best et autres

BACKGROUND Quality dashboards are increasingly being used in oncology to support monitoring and standardisation of quality of care against defined benchmarks, yet there is limited consensus or guidelines on effective dashboard design. OBJECTIVE This scoping review aims to summarise the evidence supporting …

0 citations
Accès ouvert 2025 article OpenAlex

Evaluating current quality indicators used in the care of adult patients with glioblastoma: A scoping review of the literature

CATHERINE M. DUNN, Grace Y Kim, Peter Gibbs, Lucy Gately

Background: Glioblastoma (GBM) is the most aggressive primary brain neoplasm in adults, characterized by high recurrence and poor post-recurrence survival. Validated quality indicators (QIs) have been used to assess the quality of care in many cancer populations, now providing clinicians, researchers, and …

au (code pays fourni par la source)

1 citation Neuro-Oncology Practice
Accès ouvert 2025 article OpenAlex

Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data study

Allison Drosdowsky, Karen Elaine Lamb, Luc te Marvelde, Peter Gibbs et autres

This research aimed to assess the length of intervals before diagnosis and treatment for colorectal cancer in Australia using linked datasets, and to determine any factors associated with interval length. A colorectal cancer clinical registry was linked to general practice electronic medical …

au (code pays fourni par la source)

3 citations International Journal of Cancer
2025 article OpenAlex

Preventive medication deprescribing in advanced cancer patients approaching end of life

Jane McKenzie, CATHERINE M. DUNN, Grace Gard, Brian Huong Canh Le et autres

Previous reports indicated many patients with advanced cancer and limited life expectancy have ongoing preventive medication prescription (PMP) of uncertain benefit and increased risk. Our review of palliative care oncology admissions found high rates of PMP (69%) at time of first palliative …

au (code pays fourni par la source)

0 citations Internal Medicine Journal
Accès ouvert 2024 article OpenAlex

Real‐world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer

Matthew Loft, Vanessa S. Wong, Suzanne Kosmider, Rachel Wong et autres

BACKGROUND: Immunotherapy has emerged as a standard treatment for deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC). Pembrolizumab became widely available as a first-line (1L) option in Australia following the Pharmaceutical Benefits Scheme (PBS) listing in August 2021. The uptake of new …

au (code pays fourni par la source)

1 citation Internal Medicine Journal
Accès ouvert 2024 article OpenAlex

Measuring the quality of care in metastatic colorectal cancer: a scoping review of quality indicators

CATHERINE M. DUNN, Michael T. Halpern, Daniel Sapkaroski, Peter Gibbs

BACKGROUND: Quality indicators are essential for measuring and benchmarking the quality of cancer care. Although there are well-established metrics for early-stage colorectal cancer (CRC), few exist for advanced CRC. This scoping review aimed to collate and review all quality indicators for metastatic …

au, us (code pays fourni par la source)

3 citations JNCI Cancer Spectrum
Accès ouvert 2024 article OpenAlex

Evolving patterns of metastatic spread, treatment, and outcome for patients with oligometastatic colorectal cancer

Helen Pham, Sangeetha Ramanujam, Hui‐Ling Yeoh, Phillip N. Antippa et autres

Introduction The assessment and management of oligometastatic colorectal cancer has evolved over the last two decades. We aimed to examine trends in the presentation, management and outcomes of patients presenting with liver-only disease, given recent changed standards for baseline imaging, and evolving …

au, cn (code pays fourni par la source)

1 citation Surgical Oncology Insight

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.